$ZLAB

Zai Lab Limited

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$36.89 ▲2.996%

Last Close

VOLUME

414,930

DAY RANGE

35.14 - 37.62

52 WEEK

24.5 - 181.92

Join Discuss about ZLAB with like-minded investors

profile
@Benlax #droscrew
recently

@dros any flow on zlab perchance

106 Replies 14 👍 6 🔥

profile
@Benlax #droscrew
recently

ZLAB out, SONY in. BILL starter as well

95 Replies 7 👍 12 🔥

profile
@Benlax #droscrew
recently

really tempted to cut the small zlab/futu positions and just let the money compound on $SONY

76 Replies 7 👍 15 🔥

profile
@Benlax #droscrew
recently

zlab/futu next

148 Replies 15 👍 12 🔥

profile
@Benlax #droscrew
recently

Added some ZLAB

86 Replies 8 👍 12 🔥

profile
@Benlax #droscrew
recently

considering consolidating my small futu position to zlab

114 Replies 14 👍 7 🔥

profile
@Benlax #droscrew
recently

$ZLAB and $NTES ripping today, likely your China leaders going forward

111 Replies 8 👍 11 🔥

profile
@Benlax #droscrew
recently

Small ZLAB starter as I check it out more

52 Replies 15 👍 7 🔥

profile
@Benlax #droscrew
recently

sold the last on my PINS shares. considering a few replacements, zlab is the top contender atm

46 Replies 15 👍 8 🔥

profile
@Benlax #droscrew
recently

Top of watchlist names for LT: ZI, LSCC, ZLAB, AVTR Taking any input

123 Replies 10 👍 14 🔥

profile
@Benlax #droscrew
recently

china name highly tied to NVCR, both (china and nvcr) got whacked recently and zlab hasnt moved, likely going higher

136 Replies 10 👍 6 🔥

Key Metrics

Market Cap

3.60 B

Beta

1.81

Avg. Volume

593.29 K

Shares Outstanding

97.91 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-09

Next Dividend Date

Company Information

Zai Lab ) is an innovative commercial stage biopharmaceutical company focused on bringing transformative medicines for cancer, infectious and autoimmune diseases to patients in China and around the world. To quickly target the large, fast-growing segments of China's pharmaceutical market and address unmet medical needs, Zai Lab's experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates. Zai Lab has also built an in-house team with strong drug discovery and translational research capabilities, aiming to establish a global pipeline of proprietary drug candidates against targets in itsfocus areas. Zai Lab's vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its portfolio in order to impact human health worldwide.

Website:

HQ: Pudong Shanghai, 201210 Shanghai

Related News